Flow cytometry assesses minimal residual disease in myeloma
(HealthDay)—Data on methods used for assessing minimal residual disease (MRD) in multiple myeloma (MM) are presented in a report published online Oct. 23 in the International Journal of Laboratory Hematology.
Oct 30, 2017
0
31